{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:55:38Z","timestamp":1762113338921},"reference-count":23,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":6197,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1111\/j.1476-5381.1995.tb16626.x","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T17:58:03Z","timestamp":1342720683000},"page":"1377-1381","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Antihypertensive effect of an endothelin receptor antagonist in DOCA\u2010salt spontaneously hypertensive rats"],"prefix":"10.1111","volume":"115","author":[{"given":"Ernesto L.","family":"Schiffrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavol","family":"Sventek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Turgeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Reudelhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"e_1_2_1_3_1","first-page":"228","article-title":"Pharmacological characterization of bosentan, a new potent orally active non\u2010peptide endothelin receptor antagonist","volume":"270","author":"CLOZEL M.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)96213-4"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.6.753"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.8.2863"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92270-5"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.21.6.916"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1139\/y95-050"},{"key":"e_1_2_1_10_1","first-page":"425","article-title":"Endothelin\u20101 gene expression during development of DOCA\u2010salt hypertension in the rat","volume":"24","author":"LARIVI\u00c8RE R.","year":"1994","journal-title":"Hypertension"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.21.3.294"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.24.2.183"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.4.495"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)80384-7"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600620215"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)81197-0"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114029"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.4.699"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/4.4.303"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198402000-00009"},{"key":"e_1_2_1_21_1","first-page":"F1232","article-title":"Control of renal function during intrarenal infusion of endothelin","volume":"258","author":"STACY L.D.","year":"1990","journal-title":"Am. J. Physiol."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/11.14.4879"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/332411a0"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92679-X"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1995.tb16626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1995.tb16626.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T19:40:01Z","timestamp":1695843601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1995.tb16626.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["10.1111\/j.1476-5381.1995.tb16626.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb16626.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}